Literature DB >> 16720782

Factors affecting the cohesion of impaction bone graft.

J Oakley1, J H Kuiper.   

Abstract

The role of bone-graft extenders in impaction revision surgery is becoming increasingly important. Tricalcium phosphate and hydroxyapatite have been shown to be both biocompatible and osteoconductive, yet many surgeons remain reluctant to use them. The difficulty in handling bone-graft extenders can be partly alleviated by using porous particles and adding clotted blood. In an in vitro model we measured the cohesive properties of various impaction graft mixes. Several factors were evaluated including the use of pure bone graft compared with mixes with extender, washing the bone and the addition of clotted blood. Our findings showed that pure allograft bone particles had significantly higher cohesion than when mixed with extender (p < 0.001). Washing had no effect on cohesion. The addition of clotted blood significantly increased the cohesion of both pure bone (p < 0.019) and mixes with pure bone and with porous graft extender (p < 0.044).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720782     DOI: 10.1302/0301-620X.88B6.17278

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  9 in total

1.  Clinical and radiographic assessment of cementless acetabular revision with morsellised allografts.

Authors:  Chuang Sun; Yong-Yun Lian; Yu-Hua Jin; Cheng-Bin Zhao; Shi-Qi Pan; Xue-Feng Liu
Journal:  Int Orthop       Date:  2009-02-26       Impact factor: 3.075

2.  Reduced femoral component subsidence with improved impaction grafting at revision hip arthroplasty.

Authors:  D W Howie; S A Callary; M A McGee; N C Russell; L B Solomon
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

Review 3.  [Influence of thermodisinfection on impaction of cancellous bone : An in vitro model of femoral impaction bone grafting].

Authors:  C Fölsch; A Jahnke; A Groß; G Martels; G A Krombach; M Rickert; M Kampschulte
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

Review 4.  [Allogeneic bone transplantation in hip revision surgery : Indications and potential for reconstruction].

Authors:  G A Ahmed; B Ishaque; M Rickert; C Fölsch
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

5.  Influence of antibiotic pellets on pore size and shear stress resistance of impacted native and thermodisinfected cancellous bone: An in vitro femoral impaction bone grafting model.

Authors:  C Fölsch; J Bok; G A Krombach; M Rickert; C A Fonseca Ulloa; G A Ahmed; M Kampschulte; A Jahnke
Journal:  J Orthop       Date:  2020-09-19

6.  Novel osteoconductive β-tricalcium phosphate/poly(L-lactide-co-e-caprolactone) scaffold for bone regeneration: a study in a rabbit calvarial defect.

Authors:  Hanna Pihlman; Pauli Keränen; Kaarlo Paakinaho; Jere Linden; Markus Hannula; Iida-Kaisa Manninen; Jari Hyttinen; Mikko Manninen; Outi Laitinen-Vapaavuori
Journal:  J Mater Sci Mater Med       Date:  2018-10-08       Impact factor: 3.896

7.  Defining the impaction frequency and threshold force required for femoral impaction grafting in revision hip arthroplasty. A human cadaveric mechanical study.

Authors:  Fionnan Cummins; Peter O' Reilly; Olivia Flannery; Danny Kelly; Paddy Kenny
Journal:  Acta Orthop       Date:  2011-06-21       Impact factor: 3.717

8.  Platelet concentrate as an additive to bone allografts: a laboratory study using an uniaxial compression test.

Authors:  David Putzer; Markus Dobersberger; Alex Pizzini; Debora Coraça-Huber; Christoph Ammann; Michael Nogler
Journal:  Cell Tissue Bank       Date:  2018-05-31       Impact factor: 1.522

9.  Effect of synthetic bone replacement material of different size on shear stress resistance within impacted native and thermodisinfected cancellous bone: an in vitro femoral impaction bone grafting model.

Authors:  C Fölsch; P Sahm; C A Fonseca Ulloa; G A Krombach; M Kampschulte; M Rickert; A Pruss; A Jahnke
Journal:  Cell Tissue Bank       Date:  2021-04-24       Impact factor: 1.522

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.